Product Data Sheet

BRD4-IN-4

Catalog No. A40500

main product photo
BRD4-IN-4 is a selective inhibitor of the bromodomain-containing protein 4 (BRD4) with an IC50 of 6.83 μM. This compound effectively inhibits the proliferation of MV4-11 cells and induces cell cycle arrest in the G1 phase. BRD4-IN-4 is primarily utilized in research focused on MLL leukemia, providing insights into the therapeutic potential of targeting BRD4 in cancer treatment.
Chemical Information
Catalog NumA40500
M. Wt330.40
FormulaC17H18N2O3S
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.304685-40-3
Synonyms
SMILESO=C1C2=CC=CC3=C(S(=O)(N4CCCC4)=O)C=CC(N1CC)=C32
Biological Activity
DescriptionBRD4-IN-4 is a selective inhibitor of the bromodomain-containing protein 4 (BRD4) with an IC50 of 6.83 μM. This compound effectively inhibits the proliferation of MV4-11 cells and induces cell cycle arrest in the G1 phase. BRD4-IN-4 is primarily utilized in research focused on MLL leukemia, providing insights into the therapeutic potential of targeting BRD4 in cancer treatment.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.